Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes (NCT07317115)

🧪 Interventions in This Study

• Magnet System (DEVICE)
• Semaglutide (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Westmount Surgical Center — Westmount, Quebec

📞 Contact the Study Coordinator

Phone: (763) 200-1416

Email: clinical@gtmetabolic.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Obesity (Disorder)

• Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals. — Prairie View, Texas
• Iron Metabolism in Obesity — San Pedro Garza García, Nuevo León
• Continuous Glucose Monitoring in Metabolic Surgery — Baton Rouge, Louisiana
• Healthy Living Anson Study — Chapel Hill, North Carolina
• JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity — Hamilton, Ontario
• Repeated Far Infrared Sauna Bathing in Adults With Obesity — Eugene, Oregon

Explore by condition: All Obesity (Disorder) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.